NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats
Open Access
- 15 April 2020
- journal article
- research article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 17 (4), 283-291
- https://doi.org/10.30773/pi.2019.0189
Abstract
Objective NOD-like receptor protein 1 (NLRP1) inflammasome complex has been recently associated with chronic unpredictable mild stress (CUMS) model of depression. Our aim was to investigate whether ketamine-induced antidepressant effect is associated with suppression of NLRP1. Methods Wistar albino rats were divided into control, CUMS, CUMS+acute ketamine (a single 10 mg/kg dose) and CUMS+chronic ketamine (daily 10 mg/kg injections for 3 weeks) groups (n=10 for each group). Sucrose preference test and forced swimming test were performed to assess anhedonia and immobility time respectively for the severety of depression symptoms. Brain tissues were dissected and prefrontal cortex and hippocampus regions were used for real-time polymerase chain reaction (PCR) and immunohistochemical analysis. Results CUMS procedure significantly induced depressive-like symptoms whereas both acute and chronic ketamine treatment ameliorated them. mRNA expression levels of NLRP1, caspase 1, apoptosis-associated speck-like protein containing a CARD (ASC), NF-kappa B, endothelial nitric oxide synthase, IL-1 beta, IL-6, toll-like receptor 4 (TLR-4) and purinergic 2x7 receptor (P2X7R) and numbers of Iba-1+and GFAP+glial cells were reduced by acute and/or chronic ketamine treatment. Conclusion In the present study for the first time upstream and downstream elements of the NLRP1 inflammasome complex are shown to be suppressed by ketamine thus reinforcing the involvement of NLRP1 in the physiopathology of depression.Keywords
Funding Information
- TÜBİTAK 1002 (SBAG-216S797)
- Marmara University (SAG-C-DRP-110915-0417;SAG-C-DRP-110913-0365)
This publication has 48 references indexed in Scilit:
- An astroglial basis of major depressive disorder? An overviewGlia, 2017
- 5-Bromo-2-hydroxy-4-methyl-benzaldehyde inhibited LPS-induced production of pro-inflammatory mediators through the inactivation of ERK, p38, and NF-κB pathways in RAW 264.7 macrophagesChemico-Biological Interactions, 2016
- Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effectsEuropean Psychiatry, 2015
- Neurobiology of chronic mild stress: Parallels to major depressionNeuroscience & Biobehavioral Reviews, 2012
- Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto ratsNeuroscience, 2012
- Ketamine Inhibits Lipopolysaccharide-Induced Astrocytes Activation by Suppressing TLR4/NF-?B PathwayCellular Physiology and Biochemistry, 2012
- Ketamine Inhibits Transcription Factors Activator Protein 1 and Nuclear Factor-κB, Interleukin-8 Production, as well as CD11b and CD16 Expression: Studies in Human Leukocytes and Leukocytic Cell LinesAnesthesia & Analgesia, 2010
- Spike–wave discharges are necessary for the expression of behavioral depression‐like symptomsEpilepsia, 2009
- Ketamine suppresses endotoxin-induced NF-κB expressionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- Depression: a new animal model sensitive to antidepressant treatmentsNature, 1977